You are here

Treatment with human pituitary growth hormone

Document

Creutzfeldt-Jakob disease - Treatment with human pituitary growth hormone Factor

Last reviewed for CCPS 15 May 1998.

Preliminary questions [16283]

16373 there is some evidence that treatment with human pituitary growth hormone may be a factor in the development of the condition under consideration.

16287 the veteran has had treatment with human pituitary growth hormone at some time.

16288

the veteran had treatment with human pituitary growth hormone before the clinical onset of Creutzfeldt-Jakob disease.

16289the veteran has established the causal connection between the treatment with human pituitary growth hormone and VEA service for Creutzfeldt-Jakob disease.

16292the veteran has established the causal connection between the treatment with human pituitary growth hormone and operational service for the clinical onset of Creutzfeldt-Jakob disease.

or

16293the veteran has established the causal connection between the treatment with human pituitary growth hormone and eligible service for the clinical onset of Creutzfeldt-Jakob disease.

Clinical onset and operational service [16292]

24913

the veteran had treatment with human pituitary growth hormone before the clinical onset of Creutzfeldt-Jakob disease, on operational service.

or

16294

the treatment with human pituitary growth hormone before the clinical onset of Creutzfeldt-Jakob disease was for an illness or injury which is identifiable.

16295the identified illness or injury for which treatment with human pituitary growth hormone was given is causally related to operational service.

Clinical onset and eligible service [16293]

16294

the treatment with human pituitary growth hormone before the clinical onset of Creutzfeldt-Jakob disease was for an illness or injury which is identifiable.

16296the identified illness or injury for which treatment with human pituitary growth hormone was given is causally related to eligible service.